The Role of Adiponectin in Cancer: A Review of Current Evidence

Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation, 67, 968, 10.1161/01.CIR.67.5.968

Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76

Ogden, 2006, Prevalence of overweight and obesity in the United States, 1999–2004, JAMA, 295, 1549, 10.1001/jama.295.13.1549

Ogden, 2007, The epidemiology of obesity, Gastroenterology, 132, 2087, 10.1053/j.gastro.2007.03.052

Renehan, 2008, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet, 371, 569, 10.1016/S0140-6736(08)60269-X

Pischon, 2008, Obesity and cancer, Proc Nutr Soc, 67, 128, 10.1017/S0029665108006976

Larsson, 2007, Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies, Int J Cancer, 120, 1993, 10.1002/ijc.22535

Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423

Lichtman, 2010, Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma, Oncologist, 15, 1083, 10.1634/theoncologist.2010-0206

Wiseman, 2008, The Second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective, Proc Nutr Soc, 67, 253, 10.1017/S002966510800712X

Hsing, 2007, Obesity, metabolic syndrome, and prostate cancer, Am J Clin Nutr, 86, s843, 10.1093/ajcn/86.3.843S

Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer, 4, 579, 10.1038/nrc1408

Park, 2011, Paracrine and endocrine effects of adipose tissue on cancer development and progression, Endocr Rev, 32, 550, 10.1210/er.2010-0030

van Kruijsdijk, 2009, Obesity and cancer: the role of dysfunctional adipose tissue, Cancer Epidemiol Biomarkers Prev, 18, 2569, 10.1158/1055-9965.EPI-09-0372

Barb, 2007, Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence, Am J Clin Nutr, 86, s858, 10.1093/ajcn/86.3.858S

Ziemke, 2010, Adiponectin in insulin resistance: lessons from translational research, Am J Clin Nutr, 91, 258S, 10.3945/ajcn.2009.28449C

Kelesidis, 2006, Adiponectin and cancer: a systematic review, Br J Cancer, 94, 1221, 10.1038/sj.bjc.6603051

Gallagher, 2011, Minireview: IGF, insulin, and cancer, Endocrinology, 152, 2546, 10.1210/en.2011-0231

MacDougald, 2007, The rapidly expanding family of adipokines, Cell Metab, 6, 159, 10.1016/j.cmet.2007.08.010

Hivert, 2008, Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance, J Clin Endocrinol Metab, 93, 3165, 10.1210/jc.2008-0425

Weyer, 2001, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, J Clin Endocrinol Metab, 86, 1930, 10.1210/jcem.86.5.7463

Hotta, 2000, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol, 20, 1595, 10.1161/01.ATV.20.6.1595

Paz-Filho, 2011, Associations between adipokines and obesity-related cancer, Front Biosci, 16, 1634, 10.2741/3810

Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697

Scherer, 1995, A novel serum protein similar to C1q, produced exclusively in adipocytes, J Biol Chem, 270, 26746, 10.1074/jbc.270.45.26746

Maeda, 1996, cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1), Biochem Biophys Res Commun, 221, 286, 10.1006/bbrc.1996.0587

Nakano, 1996, Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma, J Biochem, 120, 803, 10.1093/oxfordjournals.jbchem.a021483

Chandran, 2003, Adiponectin: more than just another fat cell hormone?, Diabetes Care, 26, 2442, 10.2337/diacare.26.8.2442

Garaulet, 2007, Adiponectin, the controversial hormone, Public Health Nutr, 10, 1145, 10.1017/S1368980007000638

Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem Biophys Res Commun, 257, 79, 10.1006/bbrc.1999.0255

Wong, 2004, A family of Acrp30/adiponectin structural and functional paralogs, Proc Natl Acad Sci USA, 101, 10302, 10.1073/pnas.0403760101

Wong, 2008, Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-γ agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions, Biochem J, 416, 161, 10.1042/BJ20081240

Yamauchi, 2003, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects, Nature, 423, 762, 10.1038/nature01705

Hug, 2004, T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin, Proc Natl Acad Sci USA, 101, 10308, 10.1073/pnas.0403382101

Takahashi, 2000, Genomic structure and mutations in adipose-specific gene, adiponectin, Int J Obes Relat Metab Disord, 24, 861, 10.1038/sj.ijo.0801244

Kissebah, 2000, Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc Natl Acad Sci USA, 97, 14478, 10.1073/pnas.97.26.14478

Menzaghi, 2002, A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome, Diabetes, 51, 2306, 10.2337/diabetes.51.7.2306

Kondo, 2002, Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome, Diabetes, 51, 2325, 10.2337/diabetes.51.7.2325

Kaklamani, 2008, Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk, Cancer Res, 68, 3178, 10.1158/0008-5472.CAN-08-0533

Kadowaki, 2005, Adiponectin and adiponectin receptors, Endocr Rev, 26, 439, 10.1210/er.2005-0005

Delaigle, 2004, Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies, Endocrinology, 145, 5589, 10.1210/en.2004-0503

Kaser, 2005, Adiponectin and its receptors in non-alcoholic steatohepatitis, Gut, 54, 117, 10.1136/gut.2003.037010

Fayad, 2007, Adiponectin deficiency protects mice from chemically induced colonic inflammation, Gastroenterology, 132, 601, 10.1053/j.gastro.2006.11.026

Piñeiro, 2005, Adiponectin is synthesized and secreted by human and murine cardiomyocytes, FEBS Lett, 579, 5163, 10.1016/j.febslet.2005.07.098

Katsiougiannis, 2006, Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin, Arthritis Rheum, 54, 2295, 10.1002/art.21944

Brochu-Gaudreau, 2010, Adiponectin action from head to toe, Endocrine, 37, 11, 10.1007/s12020-009-9278-8

Chen, 2006, Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines, Diabetologia, 49, 1292, 10.1007/s00125-006-0194-7

Kusminski, 2007, Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum, Diabetologia, 50, 634, 10.1007/s00125-006-0577-9

Bronsky, 2006, Adiponectin, adipocyte fatty acid binding protein, and epidermal fatty acid binding protein: proteins newly identified in human breast milk, Clin Chem, 52, 1763, 10.1373/clinchem.2005.063032

Simpson, 2010, Adiponectin—it's all about the modifications, Int J Biochem Cell Biol, 42, 785, 10.1016/j.biocel.2009.12.021

Ruan, 2003, Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α, Cytokine Growth Factor Rev, 14, 447, 10.1016/S1359-6101(03)00052-2

Fisher, 2005, Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males, Diabetologia, 48, 1084, 10.1007/s00125-005-1758-7

Tsao, 2003, Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways, J Biol Chem, 278, 50810, 10.1074/jbc.M309469200

Tsao, 2002, Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30), J Biol Chem, 277, 29359, 10.1074/jbc.C200312200

Wang, 2002, Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity, J Biol Chem, 277, 19521, 10.1074/jbc.M200601200

Shapiro, 1998, The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor, Curr Biol, 8, 335, 10.1016/S0960-9822(98)70133-2

Wang, 2006, Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex, J Biol Chem, 281, 16391, 10.1074/jbc.M513907200

Peake, 2005, The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals, Eur J Endocrinol, 153, 409, 10.1530/eje.1.01978

Waki, 2005, Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1, Endocrinology, 146, 790, 10.1210/en.2004-1096

Goldstein, 2004, Adiponectin: a novel adipokine linking adipocytes and vascular function, J Clin Endocrinol Metab, 89, 2563, 10.1210/jc.2004-0518

Kadowaki, 2006, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest, 116, 1784, 10.1172/JCI29126

Fruebis, 2001, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice, Proc Natl Acad Sci USA, 98, 2005, 10.1073/pnas.98.4.2005

Pajvani, 2003, Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity, J Biol Chem, 278, 9073, 10.1074/jbc.M207198200

Blüher, 2007, Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays, Diabetes Care, 30, 280, 10.2337/dc06-1362

Heidemann, 2008, Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women, Ann Intern Med, 149, 307, 10.7326/0003-4819-149-5-200809020-00005

Pajvani, 2004, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity, J Biol Chem, 279, 12152, 10.1074/jbc.M311113200

Berg, 2001, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nat Med, 7, 947, 10.1038/90992

Trujillo, 2005, Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome, J Intern Med, 257, 167, 10.1111/j.1365-2796.2004.01426.x

Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J Biol Chem, 279, 1304, 10.1074/jbc.M310389200

Hada, 2007, Selective purification and characterization of adiponectin multimer species from human plasma, Biochem Biophys Res Commun, 356, 487, 10.1016/j.bbrc.2007.03.004

Tilg, 2006, Adipocytokines: mediators linking adipose tissue, inflammation and immunity, Nat Rev Immunol, 6, 772, 10.1038/nri1937

Kharroubi, 2003, Expression of adiponectin receptors in pancreatic β cells, Biochem Biophys Res Commun, 312, 1118, 10.1016/j.bbrc.2003.11.042

Chinetti, 2004, Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR, Biochem Biophys Res Commun, 314, 151, 10.1016/j.bbrc.2003.12.058

Tsuchida, 2004, Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity, J Biol Chem, 279, 30817, 10.1074/jbc.M402367200

Ouchi, 2000, Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway, Circulation, 102, 1296, 10.1161/01.CIR.102.11.1296

Blüher, 2006, Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training, J Clin Endocrinol Metab, 91, 2310, 10.1210/jc.2005-2556

Blüher, 2007, Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training, Diabetes Care, 30, 3110, 10.2337/dc07-1257

Bullen, 2007, Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice, Am J Physiol Endocrinol Metab, 292, E1079, 10.1152/ajpendo.00245.2006

Blüher, 2004, Responsiveness to peripherally administered melanocortins in lean and obese mice, Diabetes, 53, 82, 10.2337/diabetes.53.1.82

Inukai, 2005, Regulation of adiponectin receptor gene expression in diabetic mice, Am J Physiol Endocrinol Metab, 288, E876, 10.1152/ajpendo.00118.2004

Blüher, 2008, Altered levels of adiponectin and adiponectin receptors may underlie the effect of ciliary neurotrophic factor (CNTF) to enhance insulin sensitivity in diet-induced obese mice, Horm Metab Res, 40, 225, 10.1055/s-2007-1004573

Tsuchida, 2005, Peroxisome proliferator-activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ, and their combination, Diabetes, 54, 3358, 10.2337/diabetes.54.12.3358

Kaltenbach, 2005, Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones, Int J Obes (Lond), 29, 760, 10.1038/sj.ijo.0802957

Holland, 2011, Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin, Nat Med, 17, 55, 10.1038/nm.2277

Villa, 2009, Sphingolipids function as downstream effectors of a fungal PAQR, Mol Pharmacol, 75, 866, 10.1124/mol.108.049809

Takabe, 2008, “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets, Pharmacol Rev, 60, 181, 10.1124/pr.107.07113

Hebbard, 2008, T-Cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model, Cancer Res, 68, 1407, 10.1158/0008-5472.CAN-07-2953

Lee, 2008, The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth, Biochemistry, 47, 11682, 10.1021/bi801451f

Mistry, 2006, The regulation of adiponectin receptors in human prostate cancer cell lines, Biochem Biophys Res Commun, 348, 832, 10.1016/j.bbrc.2006.07.139

Wu, 2012, Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells, Oncol Rep, 27, 1488

Takahata, 2007, Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells, Cancer Lett, 250, 229, 10.1016/j.canlet.2006.10.006

Takemura, 2006, Expression of adiponectin receptors and its possible implication in the human endometrium, Endocrinology, 147, 3203, 10.1210/en.2005-1510

Kim, 2010, Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation, Mol Endocrinol, 24, 1441, 10.1210/me.2009-0498

Petridou, 2007, Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies, Oncology, 73, 261, 10.1159/000127424

Dalamaga, 2009, Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study, Cancer Causes Control, 20, 625, 10.1007/s10552-008-9273-z

Körner, 2007, Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies, J Clin Endocrinol Metab, 92, 1041, 10.1210/jc.2006-1858

Bråkenhielm, 2004, Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis, Proc Natl Acad Sci USA, 101, 2476, 10.1073/pnas.0308671100

Miyazaki, 2005, Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3, Biochem Biophys Res Commun, 333, 79, 10.1016/j.bbrc.2005.05.076

Holland, 2009, PAQRs: a counteracting force to ceramides?, Mol Pharmacol, 75, 740, 10.1124/mol.109.054817

Holland, 2011, Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice, J Clin Invest, 121, 1858, 10.1172/JCI43378

Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance, Cell Metab, 5, 167, 10.1016/j.cmet.2007.01.002

Zhao, 2007, Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes, Diabetes, 56, 1210, 10.2337/db06-0719

Levine, 2007, Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK→Rac1→Akt→endothelial nitric-oxide synthase pathway, J Biol Chem, 282, 20351, 10.1074/jbc.M702182200

Buechler, 2010, Adiponectin receptor binding proteins—recent advances in elucidating adiponectin signalling pathways, FEBS Lett, 584, 4280, 10.1016/j.febslet.2010.09.035

Deepa, 2009, APPL1: role in adiponectin signaling and beyond, Am J Physiol Endocrinol Metab, 296, E22, 10.1152/ajpendo.90731.2008

Schenck, 2008, The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development, Cell, 133, 486, 10.1016/j.cell.2008.02.044

Liu, 2002, Mediation of the DCC apoptotic signal by DIP13 α, J Biol Chem, 277, 26281, 10.1074/jbc.M204679200

Miaczynska, 2004, APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment, Cell, 116, 445, 10.1016/S0092-8674(04)00117-5

Mao, 2006, APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function, Nat Cell Biol, 8, 516, 10.1038/ncb1404

Hardie, 2003, Management of cellular energy by the AMP-activated protein kinase system, FEBS Lett, 546, 113, 10.1016/S0014-5793(03)00560-X

Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat Med, 7, 941, 10.1038/90984

Yamauchi, 2007, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions, Nat Med, 13, 332, 10.1038/nm1557

Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat Med, 8, 1288, 10.1038/nm788

Miller, 2011, Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling, J Clin Invest, 121, 2518, 10.1172/JCI45942

Berg, 2002, ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism, Trends Endocrinol Metab, 13, 84, 10.1016/S1043-2760(01)00524-0

Zhou, 2009, Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways, J Biol Chem, 284, 22426, 10.1074/jbc.M109.028357

Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2

Luo, 2005, AMPK, the metabolic syndrome and cancer, Trends Pharmacol Sci, 26, 69, 10.1016/j.tips.2004.12.011

Igata, 2005, Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression, Circ Res, 97, 837, 10.1161/01.RES.0000185823.73556.06

Chandrasekar, 2008, Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN suppression, J Biol Chem, 283, 24889, 10.1074/jbc.M804236200

Pearson, 2001, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr Rev, 22, 153

Wang, 2007, Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1, J Biol Chem, 282, 7991, 10.1074/jbc.M700098200

Stefan, 2002, Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans, Diabetes, 51, 1884, 10.2337/diabetes.51.6.1884

Ouchi, 1999, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473

Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057

Chen, 2003, Adiponectin stimulates production of nitric oxide in vascular endothelial cells, J Biol Chem, 278, 45021, 10.1074/jbc.M307878200

Arita, 2002, Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell, Circulation, 105, 2893, 10.1161/01.CIR.0000018622.84402.FF

Kubota, 2007, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake, Cell Metab, 6, 55, 10.1016/j.cmet.2007.06.003

Corbetta, 2005, Adiponectin expression in human fetal tissues during mid- and late gestation, J Clin Endocrinol Metab, 90, 2397, 10.1210/jc.2004-1553

Cnop, 2003, Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex, Diabetologia, 46, 459, 10.1007/s00125-003-1074-z

Gavrila, 2003, Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies, J Clin Endocrinol Metab, 88, 4823, 10.1210/jc.2003-030214

Qiao, 2006, SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein α transcriptional complex, J Biol Chem, 281, 39915, 10.1074/jbc.M607215200

Bauche, 2006, Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice, Biochem Biophys Res Commun, 345, 1414, 10.1016/j.bbrc.2006.05.033

Hivert, 2011, Higher adiponectin levels predict greater weight gain in healthy women in the Nurses' Health Study, Obesity (Silver Spring), 19, 409, 10.1038/oby.2010.189

Weiss, 2006, Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial, Am J Clin Nutr, 84, 1033, 10.1093/ajcn/84.5.1033

Christou, 2008, Bariatric surgery reduces cancer risk in morbidly obese patients, Surg Obes Relat Dis, 4, 691, 10.1016/j.soard.2008.08.025

Sjöström, 2009, Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial, Lancet Oncol, 10, 653, 10.1016/S1470-2045(09)70159-7

Rokling-Andersen, 2007, Effects of long-term exercise and diet intervention on plasma adipokine concentrations, Am J Clin Nutr, 86, 1293, 10.1093/ajcn/86.5.1293

Friedenreich, 2011, Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women, Endocr Relat Cancer, 18, 357, 10.1530/ERC-10-0303

Moghadasi, 2012, High-intensity endurance training improves adiponectin mRNA and plasma concentrations, Eur J Appl Physiol, 112, 1207, 10.1007/s00421-011-2073-2

Gavrila, 2003, Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns, J Clin Endocrinol Metab, 88, 2838, 10.1210/jc.2002-021721

Gale, 2004, Energy homeostasis, obesity and eating disorders: recent advances in endocrinology, J Nutr, 134, 295, 10.1093/jn/134.2.295

Nishizawa, 2002, Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein, Diabetes, 51, 2734, 10.2337/diabetes.51.9.2734

Page, 2005, Testosterone administration suppresses adiponectin levels in men, J Androl, 26, 85, 10.1002/j.1939-4640.2005.tb02876.x

Xu, 2005, Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes, J Biol Chem, 280, 18073, 10.1074/jbc.M414231200

Siemińska, 2005, [Serum adiponectin levels in patients with acromegaly], Pol Merkur Lekarski, 19, 514

Sieminska, 2005, Effect of postmenopause and hormone replacement therapy on serum adiponectin levels, Metabolism, 54, 1610, 10.1016/j.metabol.2005.06.008

Tworoger, 2007, Plasma adiponectin concentrations and risk of incident breast cancer, J Clin Endocrinol Metab, 92, 1510, 10.1210/jc.2006-1975

Hroussalas, 2008, Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women, Maturitas, 59, 339, 10.1016/j.maturitas.2008.03.012

Swarbrick, 2008, Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans, Metab Syndr Relat Disord, 6, 87, 10.1089/met.2007.0029

Pischon, 2005, Association between dietary factors and plasma adiponectin concentrations in men, Am J Clin Nutr, 81, 780, 10.1093/ajcn/81.4.780

Qi, 2005, Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men, Diabetes Care, 28, 1022, 10.2337/diacare.28.5.1022

Mantzoros, 2006, Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women, Am J Clin Nutr, 84, 328, 10.1093/ajcn/84.2.328

Fargnoli, 2008, Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study, Am J Clin Nutr, 88, 1213

Williams, 2008, Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study, Diabetes Care, 31, 504, 10.2337/dc07-1952

Wedick, 2011, Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial, Nutr J, 10, 93, 10.1186/1475-2891-10-93

Yannakoulia, 2008, Dietary factors associated with plasma high molecular weight and total adiponectin levels in apparently healthy women, Eur J Endocrinol, 159, R5, 10.1530/EJE-08-0331

Aronis, 2012, Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study, Metabolism, 61, 577, 10.1016/j.metabol.2011.09.008

Schulze, 2004, Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes, Diabetes Care, 27, 1680, 10.2337/diacare.27.7.1680

Kassi, 2010, Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT, Maturitas, 67, 72, 10.1016/j.maturitas.2010.05.004

Okada, 2006, Relationship between serum adiponectin level and lipid composition in each lipoprotein fraction in adolescent children, Atherosclerosis, 188, 179, 10.1016/j.atherosclerosis.2005.10.030

Nakamura, 2009, Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension, Int Heart J, 50, 501, 10.1536/ihj.50.501

Wanders, 2010, Pharmacological effects of lipid-lowering drugs on circulating adipokines, World J Diabetes, 1, 116, 10.4239/wjd.v1.i4.116

Banga, 2009, Adiponectin translation is increased by the PPARγ agonists pioglitazone and omega-3 fatty acids, Am J Physiol Endocrinol Metab, 296, E480, 10.1152/ajpendo.90892.2008

Combs, 2002, Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization, Endocrinology, 143, 998, 10.1210/endo.143.3.8662

Maeda, 2001, PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein, Diabetes, 50, 2094, 10.2337/diabetes.50.9.2094

Yu, 2002, The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects, Diabetes, 51, 2968, 10.2337/diabetes.51.10.2968

Hanefeld, 2011, Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study, Cardiovasc Diabetol, 10, 65, 10.1186/1475-2840-10-65

Pajvani, 2003, Adiponectin: systemic contributor to insulin sensitivity, Curr Diab Rep, 3, 207, 10.1007/s11892-003-0065-2

Waki, 2003, Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin, J Biol Chem, 278, 40352, 10.1074/jbc.M300365200

Kang, 2012, Variants of the adiponectin and adiponectin receptor-1 Genes and posttransplantation diabetes mellitus in renal allograft recipients, J Clin Endocrinol Metab, 97, E129, 10.1210/jc.2011-1796

Richards, 2009, A genome-wide association study reveals variants in ARL15 that influence adiponectin levels, PLoS Genet, 5, e1000768, 10.1371/journal.pgen.1000768

Mazaki-Tovi, 2009, Maternal serum adiponectin multimers in gestational diabetes, J Perinat Med, 37, 637, 10.1515/JPM.2009.101

Li, 2009, Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 302, 179, 10.1001/jama.2009.976

Schulze, 2005, Adiponectin and future coronary heart disease events among men with type 2 diabetes, Diabetes, 54, 534, 10.2337/diabetes.54.2.534

Mantzoros, 2005, Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes, J Clin Endocrinol Metab, 90, 4542, 10.1210/jc.2005-0372

Durante-Mangoni, 2006, Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-α in chronic hepatitis C patients, Aliment Pharmacol Ther, 24, 1349, 10.1111/j.1365-2036.2006.03114.x

Delporte, 2003, Hyperadiponectinaemia in anorexia nervosa, Clin Endocrinol (Oxf), 58, 22, 10.1046/j.1365-2265.2003.01702.x

Ebina, 2009, Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction, Clin Rheumatol, 28, 445, 10.1007/s10067-008-1074-y

Senolt, 2006, Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis, Cytokine, 35, 247, 10.1016/j.cyto.2006.09.002

Zoccali, 2011, Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?, J Ren Nutr, 21, 87, 10.1053/j.jrn.2010.10.014

Chen, 2005, Hypoadiponectinemia is associated with ischemic cerebrovascular disease, Arterioscler Thromb Vasc Biol, 25, 821, 10.1161/01.ATV.0000157784.25920.a7

Söderberg, 2004, Leptin, but not adiponectin, predicts stroke in males, J Intern Med, 256, 128, 10.1111/j.1365-2796.2004.01351.x

Briana, 2009, Reviews: adipocytokines in normal and complicated pregnancies, Reprod Sci, 16, 921, 10.1177/1933719109336614

Dalamaga, 2011, Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study, Metabolism, 60, 1539, 10.1016/j.metabol.2011.03.021

Housa, 2006, Adipocytokines and cancer, Physiol Res, 55, 233, 10.33549/physiolres.930848

Petridou, 2003, Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece, J Clin Endocrinol Metab, 88, 993, 10.1210/jc.2002-021209

Dal Maso, 2004, Circulating adiponectin and endometrial cancer risk, J Clin Endocrinol Metab, 89, 1160, 10.1210/jc.2003-031716

Mantzoros, 2004, Adiponectin and breast cancer risk, J Clin Endocrinol Metab, 89, 1102, 10.1210/jc.2003-031804

Dalamaga, 2011, Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters, Menopause, 18, 1198, 10.1097/gme.0b013e31821e21f5

Wei, 2005, Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study, J Natl Cancer Inst, 97, 1688, 10.1093/jnci/dji376

Spyridopoulos, 2007, Low adiponectin levels are associated with renal cell carcinoma: a case-control study, Int J Cancer, 120, 1573, 10.1002/ijc.22526

Petridou, 2006, Adiponectin in relation to childhood myeloblastic leukaemia, Br J Cancer, 94, 156, 10.1038/sj.bjc.6602896

Petridou, 2009, Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study, J Clin Oncol, 27, 5049, 10.1200/JCO.2008.19.7525

Dalamaga, 2009, Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study, Cancer Causes Control, 20, 193, 10.1007/s10552-008-9233-7

Dalamaga, 2008, Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system, Eur J Cancer, 44, 1744, 10.1016/j.ejca.2008.04.015

Dalamaga, 2007, Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study, Oncology, 73, 26, 10.1159/000120995

Dalamaga, 2010, B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece, Cancer Causes Control, 21, 1451, 10.1007/s10552-010-9573-y

Ishikawa, 2005, Plasma adiponectin and gastric cancer, Clin Cancer Res, 11, 466, 10.1158/1078-0432.466.11.2

Goktas, 2005, Prostate cancer and adiponectin, Urology, 65, 1168, 10.1016/j.urology.2004.12.053

Giovannucci, 1995, Insulin and colon cancer, Cancer Causes Control, 6, 164, 10.1007/BF00052777

Bianchini, 2002, Overweight, obesity, and cancer risk, Lancet Oncol, 3, 565, 10.1016/S1470-2045(02)00849-5

Pais, 2009, Metabolic syndrome and risk of subsequent colorectal cancer, World J Gastroenterol, 15, 5141, 10.3748/wjg.15.5141

An, 2012, Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis, Eur J Cancer Prev, 21, 126, 10.1097/CEJ.0b013e32834c9b55

Xu, 2011, Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma, J Dig Dis, 12, 234, 10.1111/j.1751-2980.2011.00504.x

Byeon, 2010, Adiponectin and adiponectin receptor in relation to colorectal cancer progression, Int J Cancer, 127, 2758, 10.1002/ijc.25301

Sugiyama, 2009, Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway, Int J Oncol, 34, 339

Williams, 2008, Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors, Endocr Relat Cancer, 15, 289, 10.1677/ERC-07-0197

Kumor, 2009, Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients, Int J Colorectal Dis, 24, 275, 10.1007/s00384-008-0605-y

Gonullu, 2010, Association between adiponectin, resistin, insulin resistance, and colorectal tumors, Int J Colorectal Dis, 25, 205, 10.1007/s00384-009-0828-6

Guadagni, 2009, Prognostic significance of serum adipokine levels in colorectal cancer patients, Anticancer Res, 29, 3321

Ferroni, 2007, Prognostic significance of adiponectin levels in non-metastatic colorectal cancer, Anticancer Res, 27, 483

Erarslan, 2009, Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia, Dig Dis Sci, 54, 862, 10.1007/s10620-008-0440-6

Gialamas, 2011, Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer, Metabolism, 60, 1530, 10.1016/j.metabol.2011.03.020

Kemik, 2010, The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer, World J Surg Oncol, 8, 85, 10.1186/1477-7819-8-85

Otake, 2010, Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer, World J Gastroenterol, 16, 1252, 10.3748/wjg.v16.i10.1252

Catalán, 2011, Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer, J Nutr Biochem, 22, 634, 10.1016/j.jnutbio.2010.04.015

Lukanova, 2006, Serum adiponectin is not associated with risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 15, 401, 10.1158/1055-9965.EPI-05-0836

Nakajima, 2010, Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer, Cancer Sci, 101, 1286, 10.1111/j.1349-7006.2010.01518.x

Stocks, 2008, Components of the metabolic syndrome and colorectal cancer risk; a prospective study, Int J Obes (Lond), 32, 304, 10.1038/sj.ijo.0803713

Levy, 2008, Tumor markers in staging and prognosis of colorectal carcinoma, Neoplasma, 55, 138

Yamamoto, 2009, Reduced expression of the AdipoR1 gene is correlated with venous invasion in colorectal cancer, Mol Med Report, 2, 555, 10.3892/mmr_00000136

Montecucco, 2009, Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome, Diabetes Obes Metab, 11, 445, 10.1111/j.1463-1326.2008.00986.x

Kaklamani, 2008, Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk, JAMA, 300, 1523, 10.1001/jama.300.13.1523

Pechlivanis, 2009, Genetic variation in adipokine genes and risk of colorectal cancer, Eur J Endocrinol, 160, 933, 10.1530/EJE-09-0039

Carvajal-Carmona, 2009, Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK, Hum Mol Genet, 18, 1889, 10.1093/hmg/ddp109

Partida-Pérez, 2010, Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients, Cancer Biomark, 7, 117, 10.3233/CBM-2010-0154

Gornick, 2011, Adiponectin gene and risk of colorectal cancer, Br J Cancer, 105, 562, 10.1038/bjc.2011.259

He, 2011, Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population, BMC Med Genet, 12, 94, 10.1186/1471-2350-12-94

Liu, 2011, Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer, PLoS One, 6, e27301, 10.1371/journal.pone.0027301

Vrieling, 2010, Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis, Breast Cancer Res Treat, 123, 641, 10.1007/s10549-010-1116-4

Miyoshi, 2003, Association of serum adiponectin levels with breast cancer risk, Clin Cancer Res, 9, 5699

Hou, 2007, Adipocytokines and breast cancer risk, Chin Med J (Engl), 120, 1592, 10.1097/00029330-200709020-00009

Chen, 2006, Serum adiponectin and leptin levels in Taiwanese breast cancer patients, Cancer Lett, 237, 109, 10.1016/j.canlet.2005.05.047

Shahar, 2010, Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley, Asian Pac J Cancer Prev, 11, 61

Macis, 2012, Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer, J Clin Oncol, 30, 151, 10.1200/JCO.2011.35.2237

Fabian, 2012, Adiponectin: a risk biomarker and attractive target for chemoprevention, J Clin Oncol, 30, 124, 10.1200/JCO.2011.38.5500

Jeong, 2011, Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer, J Breast Cancer, 14, 96, 10.4048/jbc.2011.14.2.96

Kang, 2007, Relationship of serum adiponectin and resistin levels with breast cancer risk, J Korean Med Sci, 22, 117, 10.3346/jkms.2007.22.1.117

Gaudet, 2010, Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?, Cancer Epidemiol, 34, 580, 10.1016/j.canep.2010.05.014

Karaduman, 2007, Tissue levels of adiponectin in breast cancer patients, Med Oncol, 24, 361, 10.1007/s12032-007-0021-0

Sonmez, 2011, Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?, J BUON, 16, 227

Oh, 2011, Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study, Breast Cancer Res, 13, R34, 10.1186/bcr2856

Tian, 2007, Anthropometric measures, plasma adiponectin, and breast cancer risk, Endocr Relat Cancer, 14, 669, 10.1677/ERC-06-0089

Cust, 2009, The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study, Breast Cancer Res Treat, 113, 567, 10.1007/s10549-008-9958-8

Vona-Davis, 2007, Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression, Endocr Relat Cancer, 14, 189, 10.1677/ERC-06-0068

Lorincz, 2006, Molecular links between obesity and breast cancer, Endocr Relat Cancer, 13, 279, 10.1677/erc.1.00729

Duggan, 2011, Associations of insulin resistance and adiponectin with mortality in women with breast cancer, J Clin Oncol, 29, 32, 10.1200/JCO.2009.26.4473

Teras, 2009, No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk, Cancer Epidemiol Biomarkers Prev, 18, 2553, 10.1158/1055-9965.EPI-09-0542

Nyante, 2011, Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes, Breast Cancer Res Treat, 129, 593, 10.1007/s10549-011-1517-z

Wolk, 2001, A prospective study of obesity and cancer risk (Sweden), Cancer Causes Control, 12, 13, 10.1023/A:1008995217664

Moon, 2011, Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans, Mol Cancer Ther, 10, 2234, 10.1158/1535-7163.MCT-11-0545

Soliman, 2006, Association between adiponectin, insulin resistance, and endometrial cancer, Cancer, 106, 2376, 10.1002/cncr.21866

Rzepka-Górska, 2008, Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women, Eur J Gynaecol Oncol, 29, 594

Ashizawa, 2010, Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects, Gynecol Oncol, 119, 65, 10.1016/j.ygyno.2010.07.007

Cust, 2007, Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women, J Clin Endocrinol Metab, 92, 255, 10.1210/jc.2006-1371

Soliman, 2011, Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study, Am J Obstet Gynecol, 204, 167, 10.1016/j.ajog.2010.08.045

Chen, 2011, Genetic polymorphisms in obesity-related genes and endometrial cancer risk, Cancer

Ishikawa, 2007, Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2, Cancer Sci, 98, 1120, 10.1111/j.1349-7006.2007.00486.x

Tsukada, 2011, Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer, J Exp Clin Cancer Res, 30, 107, 10.1186/1756-9966-30-107

Nakajima, 2009, Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer, J Gastroenterol, 44, 685, 10.1007/s00535-009-0063-5

Seker, 2010, The association of serum adiponectin levels with histopathological variables in gastric cancer patients, Med Oncol, 27, 1319, 10.1007/s12032-009-9382-x

Seker, 2011, Tissue and serum adiponectin levels in patients with gastric cancer: are there any correlations between adiponectin levels and histopathological variables?, Hepatogastroenterology, 58, 1841

Thompson, 2010, Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction, Obesity (Silver Spring), 18, 2204, 10.1038/oby.2009.508

Akiyama, 2011, Visceral obesity and the risk of Barrett's esophagus, Digestion, 83, 142, 10.1159/000321810

Yildirim, 2009, Serum adiponectin levels in patients with esophageal cancer, Jpn J Clin Oncol, 39, 92, 10.1093/jjco/hyn143

Konturek, 2008, Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line, Dig Dis Sci, 53, 597, 10.1007/s10620-007-9922-1

Howard, 2010, Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma, Br J Surg, 97, 1020, 10.1002/bjs.7072

Nakajima, 2010, Adipocytokines and squamous cell carcinoma of the esophagus, J Cancer Res Clin Oncol, 136, 261, 10.1007/s00432-009-0657-6

Diao, 2009, Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma, Lipids Health Dis, 8, 48, 10.1186/1476-511X-8-48

Chang, 2007, Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis, Pancreas, 35, 16, 10.1097/MPA.0b013e3180547709

Krechler, 2011, Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus, Neoplasma, 58, 58, 10.4149/neo_2011_01_58

Stolzenberg-Solomon, 2008, Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers, Am J Epidemiol, 168, 1047, 10.1093/aje/kwn221

Grote, 2012, The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort, Int J Cancer, 130, 2428, 10.1002/ijc.26244

Pezzilli, 2010, Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms, Scand J Gastroenterol, 45, 93, 10.3109/00365520903358907

Kotani, 2009, Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan, Asian Pac J Cancer Prev, 10, 87

Sharma, 2010, Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis, Hepatology, 52, 1713, 10.1002/hep.23892

Monto, 2002, Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol, Hepatology, 36, 729, 10.1053/jhep.2002.35064

Jonsson, 2008, Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C, Hepatology, 48, 80, 10.1002/hep.22311

Ioannou, 2007, Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis, Clin Gastroenterol Hepatol, 5, 938, 10.1016/j.cgh.2007.02.039

Ohki, 2008, Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients, Clin Gastroenterol Hepatol, 6, 459, 10.1016/j.cgh.2008.02.012

Arano, 2011, Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients, Int J Cancer, 10.1002/ijc.25861

Nkontchou, 2010, Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis, J Hepatol, 53, 827, 10.1016/j.jhep.2010.04.035

Sumie, 2011, Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection, PLoS One, 6, e26840, 10.1371/journal.pone.0026840

Saxena, 2010, Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma, Gastroenterology, 139, 1762, 10.1053/j.gastro.2010.07.001

Miuma, 2009, The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma, Oncol Rep, 22, 1415, 10.3892/or_00000583

Spyridopoulos, 2009, Inverse association of leptin levels with renal cell carcinoma: results from a case-control study, Hormones (Athens), 8, 39, 10.14310/horm.2002.1220

Pinthus, 2008, Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney, Eur Urol, 54, 866, 10.1016/j.eururo.2008.02.044

Horiguchi, 2008, Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma, Jpn J Clin Oncol, 38, 106, 10.1093/jjco/hym158

Michalakis, 2007, Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study, Cancer Epidemiol Biomarkers Prev, 16, 308, 10.1158/1055-9965.EPI-06-0621

Arisan, 2009, Serum adipocytokine levels in prostate cancer patients, Urol Int, 82, 203, 10.1159/000200801

Li, 2010, A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival, Clin Chem, 56, 34, 10.1373/clinchem.2009.133272

Baillargeon, 2006, Obesity, adipokines, and prostate cancer in a prospective population-based study, Cancer Epidemiol Biomarkers Prev, 15, 1331, 10.1158/1055-9965.EPI-06-0082

Sher, 2008, Relationship between serum adiponectin and prostate cancer grade, Prostate, 68, 1592, 10.1002/pros.20823

Housa, 2008, Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer, Physiol Res, 57, 451, 10.33549/physiolres.931156

Kaklamani, 2011, Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk, Metabolism, 60, 1234, 10.1016/j.metabol.2011.01.005

Dhillon, 2011, Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, 20, 2618, 10.1158/1055-9965.EPI-11-0434

Beebe-Dimmer, 2010, Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans, Prostate Cancer Prostatic Dis, 13, 362, 10.1038/pcan.2010.27

Ross, 2004, Body mass index and risk of leukemia in older women, Cancer Epidemiol Biomarkers Prev, 13, 1810, 10.1158/1055-9965.EPI-03-2135

Strom, 2009, Obesity, weight gain, and risk of chronic myeloid leukemia, Cancer Epidemiol Biomarkers Prev, 18, 1501, 10.1158/1055-9965.EPI-09-0028

Willett, 2005, Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms, Br J Cancer, 93, 811, 10.1038/sj.bjc.6602762

Avcu, 2006, Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases, Int J Hematol, 83, 254, 10.1532/IJH97.NA0411

Yokota, 2000, Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages, Blood, 96, 1723, 10.1182/blood.V96.5.1723

Ozturk, 2012, Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients, Cytokine, 57, 61, 10.1016/j.cyto.2011.10.004

Fitter, 2010, Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?, J Clin Endocrinol Metab, 95, 3763, 10.1210/jc.2010-0086

Pamuk, 2006, Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome, J Exp Clin Cancer Res, 25, 537

Reseland, 2009, Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma, Eur J Haematol, 83, 460, 10.1111/j.1600-0609.2009.01311.x

Petridou, 2010, Adipocytokines in relation to Hodgkin lymphoma in children, Pediatr Blood Cancer, 54, 311, 10.1002/pbc.22294

Fowler, 2011, Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease, Blood, 118, 5872, 10.1182/blood-2011-01-330407

Lauta, 2003, A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications, Cancer, 97, 2440, 10.1002/cncr.11072

Ajuwon, 2005, Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes, Am J Physiol Regul Integr Comp Physiol, 288, R1220, 10.1152/ajpregu.00397.2004

Molica, 2008, Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia, Int J Hematol, 88, 374, 10.1007/s12185-008-0165-5

Molica, 2009, Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?, Adv Hematol, 2009, 287974, 10.1155/2009/287974

Moschovi, 2010, Serial plasma concentrations of adiponectin, leptin, and resistin during therapy in children with acute lymphoblastic leukemia, J Pediatr Hematol Oncol, 32, e8, 10.1097/MPH.0b013e3181b8a50c

Petridou, 2011, Insulin resistance: an independent risk factor for lung cancer?, Metabolism, 60, 1100, 10.1016/j.metabol.2010.12.002

Karapanagiotou, 2008, The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC), Lung Cancer, 61, 391, 10.1016/j.lungcan.2008.01.018

Cui, 2011, The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer, Biochem Cell Biol, 89, 308, 10.1139/o11-005

Wolin, 2010, Obesity and cancer, Oncologist, 15, 556, 10.1634/theoncologist.2009-0285

Antoniadis, 2011, Insulin resistance in relation to melanoma risk, Melanoma Res, 21, 541, 10.1097/CMR.0b013e32834b0eeb

Mantzoros, 2007, Circulating adiponectin levels in relation to melanoma: a case-control study, Eur J Cancer, 43, 1430, 10.1016/j.ejca.2007.03.026

Mitsiades, 2011, Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies, J Clin Endocrinol Metab, 96, E2023, 10.1210/jc.2010-1908

Isobe, 2009, Adiponectin and adiponectin receptors in human pheochromocytoma, J Atheroscler Thromb, 16, 442, 10.5551/jat.No885

Park, 2011, Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients, Metabolism, 60, 121, 10.1016/j.metabol.2010.02.006

Comuzzie, 2001, The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome, J Clin Endocrinol Metab, 86, 4321, 10.1210/jcem.86.9.7878

Menzaghi, 2007, Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease, Diabetes, 56, 1198, 10.2337/db06-0506

Zakikhani, 2008, The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase, Cancer Prev Res (Phila), 1, 369, 10.1158/1940-6207.CAPR-08-0081

Ogunwobi, 2006, Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells, Regul Pept, 134, 105, 10.1016/j.regpep.2006.02.001

Habeeb, 2011, Adiponectin supports cell survival in glucose deprivation through enhancement of autophagic response in colorectal cancer cells, Cancer Sci, 102, 999, 10.1111/j.1349-7006.2011.01902.x

Cong, 2007, Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2, Endocr Relat Cancer, 14, 713, 10.1677/ERC-07-0065

Grossmann, 2009, Role of the adiponectin leptin ratio in prostate cancer, Oncol Res, 18, 269, 10.3727/096504009X12596189659367

Bub, 2006, Adiponectin as a growth inhibitor in prostate cancer cells, Biochem Biophys Res Commun, 340, 1158, 10.1016/j.bbrc.2005.12.103

Sun, 2010, Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration, PLoS One, 5, e11987, 10.1371/journal.pone.0011987

Drabkin, 2010, Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC), Adv Cancer Res, 107, 39, 10.1016/S0065-230X(10)07002-8

Jardé, 2011, Molecular mechanisms of leptin and adiponectin in breast cancer, Eur J Cancer, 47, 33, 10.1016/j.ejca.2010.09.005

Treeck, 2008, Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells, Br J Cancer, 99, 1246, 10.1038/sj.bjc.6604692

Li, 2011, Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway, Nutr Cancer, 63, 80

Jardé, 2009, Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies, Endocr Relat Cancer, 16, 1197, 10.1677/ERC-09-0043

Grossmann, 2008, Effects of adiponectin on breast cancer cell growth and signaling, Br J Cancer, 98, 370, 10.1038/sj.bjc.6604166

Dieudonne, 2006, Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells, Biochem Biophys Res Commun, 345, 271, 10.1016/j.bbrc.2006.04.076

Nakayama, 2008, Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis, Breast Cancer Res Treat, 112, 405, 10.1007/s10549-007-9874-3

Grossmann, 2008, Balance of adiponectin and leptin modulates breast cancer cell growth, Cell Res, 18, 1154, 10.1038/cr.2008.293

Liu, 2008, Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1, Carcinogenesis, 29, 2195, 10.1093/carcin/bgn194

Dos Santos, 2008, Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells, Oncol Rep, 20, 971

Wang, 2006, Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice, Cancer Res, 66, 11462, 10.1158/0008-5472.CAN-06-1969

Kang, 2005, Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell, Arch Pharm Res, 28, 1263, 10.1007/BF02978210

Pfeiler, 2008, Adiponectin effects on human breast cancer cells are dependent on 17-β estradiol, Oncol Rep, 19, 787

Lang, 2009, Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration, Cell Commun Signal, 7, 27, 10.1186/1478-811X-7-27

Nkhata, 2009, Effects of adiponectin and leptin co-treatment on human breast cancer cell growth, Oncol Rep, 21, 1611

Arditi, 2007, Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer, Horm Metab Res, 39, 9, 10.1055/s-2007-956518

Taliaferro-Smith, 2009, LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells, Oncogene, 28, 2621, 10.1038/onc.2009.129

Kim, 2009, Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation, Cancer Res, 69, 4018, 10.1158/0008-5472.CAN-08-2641

Man, 2010, Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling, Clin Cancer Res, 16, 967, 10.1158/1078-0432.CCR-09-1487

Tang, 2009, Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-κB pathways, Prostate, 69, 1781, 10.1002/pros.21029

Chiu, 2009, Involvement of AdipoR receptor in adiponectin-induced motility and α2β1 integrin upregulation in human chondrosarcoma cells, Carcinogenesis, 30, 1651, 10.1093/carcin/bgp156

Aaronson, 1991, Growth factors and cancer, Science, 254, 1146, 10.1126/science.1659742

Wang, 2005, Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner, J Biol Chem, 280, 18341, 10.1074/jbc.M501149200

Fenton, 2008, Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells, Int J Cancer, 122, 2437, 10.1002/ijc.23436

Ogunwobi, 2008, Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation, Mol Cell Endocrinol, 285, 43, 10.1016/j.mce.2008.01.023

Fenton, 2010, Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3, Mol Carcinog, 49, 700, 10.1002/mc.20644

Rondini, 2011, Energy balance modulates colon tumor growth: interactive roles of insulin and estrogen, Mol Carcinog, 50, 370, 10.1002/mc.20720

Landskroner-Eiger, 2009, Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo, Clin Cancer Res, 15, 3265, 10.1158/1078-0432.CCR-08-2649

Denzel, 2009, Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer, Clin Cancer Res, 15, 3256, 10.1158/1078-0432.CCR-08-2661

Shackelford, 2009, The LKB1-AMPK pathway: metabolism and growth control in tumour suppression, Nat Rev Cancer, 9, 563, 10.1038/nrc2676

Barb, 2007, Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway, Endocr Relat Cancer, 14, 995, 10.1677/ERC-06-0091

Sablina, 2007, The role of PP2A A subunits in tumor suppression, Cell Adh Migr, 1, 140, 10.4161/cam.1.3.4986

Fresno Vara, 2004, PI3K/Akt signalling pathway and cancer, Cancer Treat Rev, 30, 193, 10.1016/j.ctrv.2003.07.007

Lam, 2009, Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities, PLoS One, 4, e4968, 10.1371/journal.pone.0004968

Dhillon, 2007, MAP kinase signalling pathways in cancer, Oncogene, 26, 3279, 10.1038/sj.onc.1210421

Bowman, 2000, STATs in oncogenesis, Oncogene, 19, 2474, 10.1038/sj.onc.1203527

Karim, 2004, The significance of the Wnt pathway in the pathology of human cancers, Pathology, 36, 120, 10.1080/00313020410001671957

Turecková, 2006, Expression of β-catenin is regulated by PI-3 kinase and sodium butyrate in colorectal cancer cells, Int J Mol Med, 17, 69

Karin, 2002, NF-κB in cancer: from innocent bystander to major culprit, Nat Rev Cancer, 2, 301, 10.1038/nrc780

Fruehauf, 2007, Reactive oxygen species: a breath of life or death?, Clin Cancer Res, 13, 789, 10.1158/1078-0432.CCR-06-2082

Brown, 2010, Obesity and breast cancer: progress to understanding the relationship, Cancer Res, 70, 4, 10.1158/0008-5472.CAN-09-2257

Fox, 2009, Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways, Steroids, 74, 622, 10.1016/j.steroids.2008.10.014

Silva, 2004, Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis, Oncogene, 23, 8017, 10.1038/sj.onc.1208159

Mutoh, 2011, Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice, Gastroenterology, 140, 2000, 10.1053/j.gastro.2011.02.019

Otani, 2010, Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice, Cancer Lett, 288, 177, 10.1016/j.canlet.2009.06.037

Nishihara, 2008, Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice, World J Gastroenterol, 14, 6473, 10.3748/wjg.14.6473

Sonoshita, 2001, Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice, Nat Med, 7, 1048, 10.1038/nm0901-1048

Kamada, 2007, Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model, J Hepatol, 47, 556, 10.1016/j.jhep.2007.03.020

White, 2010, Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth, J Gastrointest Surg, 14, 1888, 10.1007/s11605-010-1349-x

Endo, 2009, Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions, Gut, 58, 1637, 10.1136/gut.2009.183624

Yan, 2010, Effects of dietary fat on spontaneous metastasis of Lewis lung carcinoma in mice, Clin Exp Metastasis, 27, 581, 10.1007/s10585-010-9347-7

Yun, 2010, Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models, Cancer Prev Res (Phila), 3, 1259, 10.1158/1940-6207.CAPR-10-0087

Zyromski, 2009, Obesity potentiates the growth and dissemination of pancreatic cancer, Surgery, 146, 258, 10.1016/j.surg.2009.02.024

Rogozina, 2011, Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis, Cancer Prev Res (Phila), 4, 568, 10.1158/1940-6207.CAPR-10-0140

Fujisawa, 2008, Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition, Gut, 57, 1531, 10.1136/gut.2008.159293

Ealey, 2009, Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis, Int J Cancer, 124, 2226, 10.1002/ijc.24187

Lin, 2000, Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice, Int J Obes Relat Metab Disord, 24, 639, 10.1038/sj.ijo.0801209

Pollak, 2004, Insulin-like growth factors and neoplasia, Nat Rev Cancer, 4, 505, 10.1038/nrc1387

Manousos, 1999, IGF-I and IGF-II in relation to colorectal cancer, Int J Cancer, 83, 15, 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y

Moschos, 2002, The role of the IGF system in cancer: from basic to clinical studies and clinical applications, Oncology, 63, 317, 10.1159/000066230

Petridou, 1999, Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia, Int J Cancer, 80, 494, 10.1002/(SICI)1097-0215(19990209)80:4<494::AID-IJC2>3.0.CO;2-K

Bohlke, 1998, Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast, Epidemiology, 9, 570, 10.1097/00001648-199809000-00018

Wolk, 1998, Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study, J Natl Cancer Inst, 90, 911, 10.1093/jnci/90.12.911

Spentzos, 2007, IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer, Endocr Relat Cancer, 14, 781, 10.1677/ERC-06-0073

Petridou, 2001, Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia, Oncology, 60, 252, 10.1159/000055326

Petridou, 2000, Endogenous risk factors for childhood leukemia in relation to the IGF system (Greece). The Childhood Haematologists-Oncologists Group, Cancer Causes Control, 11, 765, 10.1023/A:1008988819494

Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724

Cowherd, 2010, Adiponectin lowers glucose production by increasing SOGA, Am J Pathol, 177, 1936, 10.2353/ajpath.2010.100363

Furukawa, 2004, Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages, Biochem Biophys Res Commun, 317, 831, 10.1016/j.bbrc.2004.03.123

Paillasse, 2009, Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion, J Lipid Res, 50, 2203, 10.1194/jlr.M800668-JLR200

Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205

Kim, 2008, Circulating levels of inflammatory cytokines and risk of colorectal adenomas, Cancer Res, 68, 323, 10.1158/0008-5472.CAN-07-2924

Wulster-Radcliffe, 2004, Adiponectin differentially regulates cytokines in porcine macrophages, Biochem Biophys Res Commun, 316, 924, 10.1016/j.bbrc.2004.02.130

Kumada, 2004, Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages, Circulation, 109, 2046, 10.1161/01.CIR.0000127953.98131.ED

Lovren, 2010, Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages, Am J Physiol Heart Circ Physiol, 299, H656, 10.1152/ajpheart.00115.2010

Ouedraogo, 2007, Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo, J Clin Invest, 117, 1718, 10.1172/JCI29623

Takemura, 2007, Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies, J Clin Invest, 117, 375, 10.1172/JCI29709

Kim, 2006, Adiponectin is a negative regulator of NK cell cytotoxicity, J Immunol, 176, 5958, 10.4049/jimmunol.176.10.5958

Tsang, 2011, Novel immunomodulatory effects of adiponectin on dendritic cell functions, Int Immunopharmacol, 11, 604, 10.1016/j.intimp.2010.11.009

Okamoto, 2008, Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis, Circ Res, 102, 218, 10.1161/CIRCRESAHA.107.164988

Yokota, 2003, Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells, J Immunol, 171, 5091, 10.4049/jimmunol.171.10.5091

Folco, 2009, Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10, J Biol Chem, 284, 25569, 10.1074/jbc.M109.019786

Kerbel, 2000, Tumor angiogenesis: past, present and the near future, Carcinogenesis, 21, 505, 10.1093/carcin/21.3.505

Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat Rev Cancer, 8, 592, 10.1038/nrc2442

Kobayashi, 2004, Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin, Circ Res, 94, e27, 10.1161/01.RES.0000119921.86460.37

Shibata, 2004, Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling, J Biol Chem, 279, 28670, 10.1074/jbc.M402558200

Shibata, 2008, Adiponectin promotes endothelial progenitor cell number and function, FEBS Lett, 582, 1607, 10.1016/j.febslet.2008.04.006

Yang, 2006, Adiponectin promotes endothelial cell differentiation from human peripheral CD14+ monocytes in vitro, J Cell Mol Med, 10, 459, 10.1111/j.1582-4934.2006.tb00411.x

Nakamura, 2009, Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1, FEBS Lett, 583, 2457, 10.1016/j.febslet.2009.07.011

Leicht, 2011, Adiponectin pretreatment counteracts the detrimental effect of a diabetic environment on endothelial progenitors, Diabetes, 60, 652, 10.2337/db10-0240

Adachi, 2006, An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways, Virchows Arch, 448, 311, 10.1007/s00428-005-0098-9

Rose, 2004, Obesity, adipocytokines, and insulin resistance in breast cancer, Obes Rev, 5, 153, 10.1111/j.1467-789X.2004.00142.x

Talmadge, 2007, Murine models to evaluate novel and conventional therapeutic strategies for cancer, Am J Pathol, 170, 793, 10.2353/ajpath.2007.060929

Sikder, 2003, Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors, Cancer Cell, 4, 291, 10.1016/S1535-6108(03)00245-9

Sata, 2004, Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis, Hypertension, 43, 1214, 10.1161/01.hyp.0000126186.29571.41

Otvos, 2011, Design and development of a peptide-based adiponectin receptor agonist for cancer treatment, BMC Biotechnol, 11, 90, 10.1186/1472-6750-11-90

Higgins, 2008, The development of INT131 as a selective PPARγ modulator: approach to a safer insulin sensitizer, PPAR Res, 2008, 936906, 10.1155/2008/936906

Mueller, 2000, Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer, Proc Natl Acad Sci USA, 97, 10990, 10.1073/pnas.180329197

Dormandy, 2005, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9

Kahn, 2006, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy, N Engl J Med, 355, 2427, 10.1056/NEJMoa066224

Nesto, 2004, Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association, Diabetes Care, 27, 256, 10.2337/diacare.27.1.256

Higgins, 2010, Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation, Am J Clin Nutr, 91, 267S, 10.3945/ajcn.2009.28449E